本月全球药品研发进展取得成效的药物有44个,比上月增加6个,除进入注册前阶段的药品数量下降外,其余均大幅增加。进入注册阶段的有21个,比上月增加8个。全球首次注册的新活性物质有6个,新制剂有3个,其余12个均为在新市场补充注册。 There were 44 drugs that made progress in global drug development this month, an increase of 6 last month, with a sharp increase in the number of drugs that entered the pre-registration phase. There were 21 entries in the registration phase, an increase of 8 from the previous month. There are 6 new active substances registered in the world for the first time, 3 for the new formulation and 12 for the new market.